Synaptial Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Jaipur, Rajasthan, India, established in 2021.

2021 Jaipur, Rajasthan, India Active

Last Updated: February 26, 2026

About Synaptial Pharmaceuticals Private Limited

Synaptial Pharmaceuticals Private Limited, a active private limited company, was established on 30 June 2021 in Jaipur, Rajasthan, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24234RJ2021PTC075602. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.60 M.

Its leadership includes Raghavendra Kumar Singh (Director), Paras Nath Singh (Director), Sonu Dokania (Director). It is based at Room No. - 1, House No - 96, Deep Vihar Benad Road, Jhotwara, Jaipur, Rajasthan, 302012.

Company Details

CIN/LLPIN
U24234RJ2021PTC075602
Registration Number
075602
Incorporation Date
30 June 2021
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.60 M
ROC Code
Roc Jaipur
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 26-02-2026
Paid Up Capital ₹ 0.60 M as on 26-02-2026
Company Age 4 Year, 8 Months

Comprehensive Company Insights

Explore comprehensive insights into Synaptial Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Synaptial Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Raghavendra Kumar Singh	Director	30 Jun 2021	Current
Paras Nath Singh	Director	30 Jun 2021	Current
Sonu Dokania	Director	30 Jun 2021	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synaptial Pharmaceuticals.

Enhance accessibility to Synaptial Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synaptial Pharmaceuticals?

Unlock access to Synaptial Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synaptial Pharmaceuticals?

Synaptial Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Synaptial Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synaptial Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synaptial Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Raghavendra Kumar Singh was appointed as a Director was appointed as a Director on 30 Jun 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
30 Jun 2021
Director Appointment

Progress on Paras Nath Singh was appointed as a Director was appointed as a Director on 30 Jun 2021 & has been associated with this company since 4 years 8 months . was documented.
30 Jun 2021
Director Appointment

Progress on Sonu Dokania was appointed as a Director was appointed as a Director on 30 Jun 2021 & has been associated with this company since 4 years 8 months . was documented.
30 Jun 2021
Company Incorporation

The activity Synaptial Pharmaceuticals Private Limited was registered on 30 Jun 2021 with Roc Jaipur & aged 4 years 8 months as per MCA records. was completed.
30 Jun 2021

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Synaptial Pharmaceuticals Private Limited?

The CIN of Synaptial Pharmaceuticals Private Limited is U24234RJ2021PTC075602.

Where is Synaptial Pharmaceuticals Private Limited headquartered?

Synaptial Pharmaceuticals Private Limited is headquartered at Room No. - 1, House No - 96, Deep Vihar Benad Road, Jhotwara, Jaipur, Rajasthan, 302012.

When was Synaptial Pharmaceuticals Private Limited incorporated?

Synaptial Pharmaceuticals Private Limited was incorporated on 30 June 2021.

Who are the current directors of Synaptial Pharmaceuticals Private Limited?

The current directors of Synaptial Pharmaceuticals Private Limited are

What is the primary industry of Synaptial Pharmaceuticals Private Limited?

The primary industry of Synaptial Pharmaceuticals Private Limited is Chemicals.

Is Synaptial Pharmaceuticals Private Limited a listed company?

Synaptial Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Synaptial Pharmaceuticals Private Limited?

The authorized capital of Synaptial Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.60 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available